RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+15.44%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$855M
AUM Growth
+$855M
(-2.3%)
Cap. Flow
-$110M
Cap. Flow
% of AUM
-12.86%
Top 10 Holdings %
Top 10 Hldgs %
29.46%
Holding
101
New
12
Increased
18
Reduced
37
Closed
8
Top Buys
| 1 |
LivaNova
LIVN
|
$11.7M |
| 2 |
Exact Sciences
EXAS
|
$8.66M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
$7.76M |
| 4 |
MacroGenics
MGNX
|
$7.64M |
| 5 |
Nektar Therapeutics
NKTR
|
$7.37M |
Top Sells
| 1 |
Biogen
BIIB
|
$18.1M |
| 2 |
Incyte
INCY
|
$14.3M |
| 3 |
CELG
Celgene Corp
CELG
|
$14.2M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
$13.6M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12.7M |
Sector Composition
| 1 | Healthcare | 93.64% |
| 2 | Technology | 0.15% |
| 3 | Energy | 0.14% |
| 4 | Financials | 0.1% |
| 5 | Communication Services | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AERI
26
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $12.4M | 1.44% |
260,000
-20,000
| -7% | -$950K |
|
|
IMMU
27
DELISTED
Immunomedics Inc
IMMU
| $11.8M | 1.38% |
616,367
+136,037
| +28% | +$2.61M |
|
|
MYOK
28
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $11.7M | 1.37% |
225,024
+35,702
| +19% | +$1.86M |
|
|
ITCI
29
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $11.6M | 1.35% |
949,833
+289,851
| +44% | +$3.53M |
|
|
SGEN
30
DELISTED
Seagen Inc. Common Stock
SGEN
| $11M | 1.29% |
150,598
-91,600
| -38% | -$6.71M |
|
31
Bristol-Myers Squibb
BMY
$96.7B
| $11M | 1.28% |
230,000
-140,000
| -38% | -$6.68M |
|
32
Centene
CNC
$14.8B
| $10.6M | 1.24% |
200,000
+80,000
| +67% | -$2.12M |
|
|
ARNA
33
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $10.5M | 1.23% |
234,558
-137,300
| -37% | -$6.16M |
|
34
FibroGen
FGEN
$48.4M
| $10.3M | 1.2% |
189,491
-112,236
| -37% | -$6.1M |
|
35
Exelixis
EXEL
$9.95B
| $10.2M | 1.2% |
430,000
-528,994
| -55% | -$12.6M |
|
36
Xencor
XNCR
$594M
| $10.1M | 1.18% |
325,965
+107,428
| +49% | +$3.34M |
|
|
MRTX
37
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $9.32M | 1.09% |
127,093
+42,093
| +50% | +$3.09M |
|
38
Cencora
COR
$57.2B
| $9.27M | 1.08% |
116,520
+15,000
| +15% | +$1.19M |
|
|
WBA
39
DELISTED
Walgreens Boots Alliance
WBA
| $9.17M | 1.07% |
145,000
| – | – |
|
|
40
Exact Sciences
EXAS
$9.33B
| $8.66M | 1.01% |
+100,000
| New | +$8.66M |
|
|
BLUE
41
DELISTED
bluebird bio
BLUE
| $8.65M | 1.01% |
55,000
-62,850
| -53% | -$9.89M |
|
|
42
Incyte
INCY
$17B
| $8.6M | 1.01% |
100,000
-166,416
| -62% | -$14.3M |
|
43
Agios Pharmaceuticals
AGIO
$2.36B
| $8.57M | 1% |
127,012
| – | – |
|
44
Alnylam Pharmaceuticals
ALNY
$58.6B
| $8.56M | 1% |
91,550
-20,000
| -18% | -$1.87M |
|
45
Iovance Biotherapeutics
IOVA
$800M
| $8.37M | 0.98% |
879,600
-325,895
| -27% | -$3.1M |
|
|
SAGE
46
DELISTED
Sage Therapeutics
SAGE
| $8.21M | 0.96% |
51,639
-85,700
| -62% | -$13.6M |
|
47
Thermo Fisher Scientific
TMO
$183B
| $8.21M | 0.96% |
30,000
| – | – |
|
48
Omnicell
OMCL
$1.51B
| $8.11M | 0.95% |
100,375
| – | – |
|
49
Sangamo Therapeutics
SGMO
$161M
| $8.05M | 0.94% |
843,957
-260,000
| -24% | -$2.48M |
|
|
AMRN
50
Amarin Corp
AMRN
$311M
| $7.7M | 0.9% |
370,800
+270,800
| +271% | +$5.62M |
|